Utama › Kanser Serviks › Oklahoma
Kajian klinikal Kanser Serviks di Oklahoma
11 kajian untuk Kanser Serviks sedang mencari peserta di lokasi di Oklahoma.
Bandar di Oklahoma
Teks kajian rasmi (Bahasa Inggeris)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
Mengambil pesertaFasa 4
Umur 18 ke atas · Wanita · Dikemas kini 25 Sep 2026 · NCT06952660A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Oklahoma Cancer Specialists and Research Institute, LLC ( Site 6001), Tulsa
Mengambil pesertaFasa 3
Umur 18 ke atas · Wanita · Dikemas kini 25 Sep 2026 · NCT07216703A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Oklahoma City
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT07182149Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
- University of Oklahoma Health Sciences Center, Oklahoma City
- University of Oklahoma, Oklahoma City
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 25 ke atas · Wanita · Dikemas kini 31 Jul 2026 · NCT07281430A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
- Stephenson Cancer Center, Oklahoma City
Mengambil peserta
Umur 18 ke atas · Wanita · Dikemas kini 30 Jul 2026 · NCT04831580A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- OU Health University of Oklahoma Medical Center, Oklahoma City
- Stephenson Cancer Center (chemo location), Oklahoma City
- University of Oklahoma Health Science Center, Oklahoma City
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Jul 2026 · NCT04389632A Study to Evaluate Lenti-HPV-07 Immunotherapy Against HPV+ Cervical or Oropharyngeal Cancer
- Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Feb 2026 · NCT06319963A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
- Dren Investigational Site, Oklahoma City
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jan 2026 · NCT06999187SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774A Phase 2 Study of Avutometinib (VS-6766) Plus Defactinib
- Stephenson Cancer Center, Oklahoma City
Mengambil pesertaFasa 2
Umur 18 hingga 99 · Wanita · Dikemas kini 22 Okt 2025 · NCT05512208A Study of NX-1607 in Adults With Advanced Malignancies
- University of Oklahoma, Oklahoma City
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2025 · NCT05107674Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.